Ted Henderson — SCHOONER CAPITAL

TEAM

Vin Ryan
Rachel Billings
Peter Binas
Antonio Cienfuegos
Jon Corbett
Laurie Finkielsztein
Orhan Gazelle
Ted Henderson
Solita Im
Steve Maiocco
Alexandra Manick
Julia Pettengill
Brian Rodgers
Lou Stathis
Isabel Vinson
Chan Won

TED HENDERSON

Ted serves as Schooner Capital’s Chief Executive Officer, with time allocated to internal management, asset allocation and firm strategy. Over the past several decades, Ted has invested primarily in venture-stage companies, guiding Schooner’s migration back to its roots in direct investing. A Managing Partner, he currently is a director at Brixton Biosciences and SRS Medical. He led Schooner healthcare sector investments including Cartesian Therapeutics (NASDAQ:RNAC), Millstone Medical Outsourcing (acquired by Arlington Capital), 4G Clinical (Goldman Sachs Asset Management), Topokine Therapeutics (Allergan), Mimetogen Pharmaceuticals (Allergan), and Best Doctors (Brown Brothers). He also led investments in Seventh Generation (Unilever), Zixi (Clearwater Capital), MediaSilo (Marlin Equity), Spotted Risk (CAC Group) and StyleFeeder (Time Inc.). Ted is a past director at several not-for-profits and co-chaired Friends of Dartmouth Soccer. He has an MBA from Harvard Business School and graduated cum laude from Dartmouth College, studying Mandarin.